Novel 2-(Diphenylmethylidene) Malonic Acid Derivatives as Anti-HIV Agents: Molecular Modeling, Synthesis and Biological Evaluation
| Author | Mehrnaz Lotfaliei | en |
| Author | Elham Rezaee | en |
| Author | Zahra Hajimahdi | en |
| Author | Mohammad Mahboubi Rabbani | en |
| Author | Rezvan Zabihollahi | en |
| Author | Mohammad Reza Aghasadeghi | en |
| Author | Sayyed Abbas Tabatabai | en |
| Orcid | Mehrnaz Lotfaliei [0000-0003-2444-7328] | en |
| Orcid | Elham Rezaee [0000-0002-6458-0097] | en |
| Orcid | Zahra Hajimahdi [0000-0001-5866-4895] | en |
| Orcid | Sayyed Abbas Tabatabai [0000-0002-7363-3517] | en |
| Issued Date | 2022-01-31 | en |
| Abstract | HIV, the virus that causes AIDS (acquired immunodeficiency syndrome), is one of the world's most severe health and development challenges. In this study, a novel series of 2-(diphenyl methylidene) malonic acid derivatives were designed as triple inhibitors of HIV reverse transcriptase, integrase, and protease. Docking models revealed that the target compounds have appropriate affinities to the active sites of the three HIV key enzymes. The synthesized malonic acid analogs were evaluated for their activities against the HIV virus (NL4-3) in HeLa cells cultures. Among them, compound 3 was the most potent anti-HIV agent with 55.20% inhibition at 10 μM and an EC50 of 8.4 μM. Interestingly, all the synthesized compounds do not show significant cytotoxicity at a concentration of 10 μM. As a result, these compounds may serve as worthy hits for the development of novel anti-HIV-agents. | en |
| DOI | https://doi.org/10.5812/ijpr.123827 | en |
| Keyword | Molecular Docking | en |
| Keyword | Synthesis | en |
| Keyword | Malonic Acid S | en |
| Keyword | Anti-HIV | en |
| Keyword | Drug Multiple Ligands | en |
| Publisher | Brieflands | en |
| Title | Novel 2-(Diphenylmethylidene) Malonic Acid Derivatives as Anti-HIV Agents: Molecular Modeling, Synthesis and Biological Evaluation | en |
| Type | Research Article | en |